• Citer

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.

par Delwaide, Jean;Bourgeois, Nadine ;Gérard, C.;De Maeght, S;Mokaddem, F;Wain, E;Bastens, Boris;Fevery, J;Géhénot, M;Le Moine, Olivier ;Martinet, Jean-Paul;Robaeys, Geert;Servais, Bruno ;Van Gossum, Marc ;Van Vlierberghe, Hans;Belgian Association for the Study of the Liver (BASL),
Référence Alimentary pharmacology & therapeutics, 20, 1, page (15-22)
Publication Publié, 2004-07

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Auteur:	Delwaide, Jean; Bourgeois, Nadine; Gérard, C.; De Maeght, S; Mokaddem, F; Wain, E; Bastens, Boris; Fevery, J; Géhénot, M; Le Moine, Olivier; Martinet, Jean-Paul; Robaeys, Geert; Servais, Bruno; Van Gossum, Marc; Van Vlierberghe, Hans; Belgian Association for the Study of the Liver (BASL),
Informations sur la publication:	Alimentary pharmacology & therapeutics, 20, 1, page (15-22)
Statut de publication:	Publié, 2004-07
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Acute Disease
	Adolescent
	Adult
	Antiviral Agents -- therapeutic use
	Female
	Hepatitis C -- drug therapy
	Humans
	Interferon-alpha -- therapeutic use
	Male
	Middle Aged
	Prospective Studies
	Recombinant Proteins
	Remission, Spontaneous
	Risk Factors
	Treatment Outcome
	Viral Load
Note générale:	Clinical Trial
	Controlled Clinical Trial
	Journal Article
	Multicenter Study
	FLWIN
Langue:	Anglais
Identificateurs:	urn:issn:0269-2813
	info:doi/10.1111/j.1365-2036.2004.02023.x
	info:pii/APT2023
	info:scp/3142723140
	info:pmid/15225166